Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion type Assertion NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_head.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion description "[Two key events that may underlie the antitumor activity of rapamycin were decreased expression of ErbB3 and inhibition of hypoxia-inducible factor-1-dependent responses to hypoxic stress.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_provenance.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion evidence source_evidence_literature NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_provenance.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion SIO_000772 15958580 NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_provenance.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion wasDerivedFrom befree-20150227 NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_provenance.
- NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_assertion wasGeneratedBy ECO_0000203 NP380974.RANgK1EwdbFTKHje0Zp_cEku8VcCMhSuHYmQkB_R5oi9c130_provenance.